JAQINALT Trademark

Trademark Overview


On Friday, April 24, 2015, a trademark application was filed for JAQINALT with the United States Patent and Trademark Office. The USPTO has given the JAQINALT trademark a serial number of 86608926. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 21, 2016. This trademark is owned by Pfizer Inc.. The JAQINALT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
jaqinalt

General Information


Serial Number86608926
Word MarkJAQINALT
Filing DateFriday, April 24, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 21, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 23, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 5, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Monday, November 21, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 21, 2016ABANDONMENT - NO USE STATEMENT FILED
Tuesday, April 19, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 23, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 23, 2016PUBLISHED FOR OPPOSITION
Wednesday, February 3, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 19, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, January 12, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 10, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 10, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 8, 2015ASSIGNED TO LIE
Friday, November 20, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 8, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 8, 2015NON-FINAL ACTION E-MAILED
Wednesday, July 8, 2015NON-FINAL ACTION WRITTEN
Wednesday, July 1, 2015ASSIGNED TO EXAMINER
Tuesday, May 5, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, April 28, 2015NEW APPLICATION ENTERED IN TRAM